Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1142

1.

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, Zhang W, Li Y, Dave BJ, Nairismägi ML, Greiner TC, Vose J, Weisenburger DD, Lachel C, Wang C, Fu K, Stevens JM, Lim ST, Ong CK, Gascoyne RD, Missiaglia E, Lemonnier F, Haioun C, Hartmann S, Pedersen MB, Laginestra MA, Wilcox RA, Teh BT, Yoshida N, Ohshima K, Seto M, Rosenwald A, Ott G, Campo E, Rimsza LM, Jaffe ES, Braziel RM, d'Amore F, Inghirami G, Bertoni F, de Leval L, Gaulard P, Staudt LM, McKeithan TW, Pileri S, Chan WC, Iqbal J.

Blood. 2019 Feb 19. pii: blood-2018-09-872549. doi: 10.1182/blood-2018-09-872549. [Epub ahead of print]

PMID:
30782609
2.

A T-cell-engaging B7-H4/CD3 bispecific Fab-scFv antibody targets human breast cancer.

Iizuka A, Nonomura C, Ashizawa T, Kondou R, Ohshima K, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Maruyama K, Yamaguchi K, Akiyama Y.

Clin Cancer Res. 2019 Feb 8. pii: clincanres.3123.2017. doi: 10.1158/1078-0432.CCR-17-3123. [Epub ahead of print]

PMID:
30737243
3.

Clinicopathological features of HCV-positive splenic diffuse large B cell lymphoma.

Shimono J, Miyoshi H, Arakawa F, Yamada K, Sugio T, Miyawaki K, Eto T, Miyagishima T, Kato K, Nagafuji K, Akashi K, Teshima T, Ohshima K.

Ann Hematol. 2019 Feb 7. doi: 10.1007/s00277-019-03628-8. [Epub ahead of print]

PMID:
30729289
4.

Identification of a novel CCDC22 mutation in a patient with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia.

Yamashita Y, Nishikawa A, Iwahashi Y, Fujimoto M, Sasaki I, Mishima H, Kinoshita A, Hemmi H, Kanazawa N, Ohshima K, Imadome KI, Murata SI, Yoshiura KI, Kaisho T, Sonoki T, Tamura S.

Int J Hematol. 2019 Jan 31. doi: 10.1007/s12185-019-02595-0. [Epub ahead of print]

PMID:
30706328
5.

Publisher Correction: Defective Epstein-Barr virus in chronic active infection and haematological malignancy.

Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H.

Nat Microbiol. 2019 Jan 30. doi: 10.1038/s41564-019-0387-8. [Epub ahead of print]

PMID:
30705423
6.

Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.

Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronné L, Kogure Y, Sato Y, Nishida K, Gion Y, Shiraishi Y, Tanaka H, Chiba K, Watatani Y, Kakiuchi N, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Sanada M, Onozawa M, Teshima T, Yoshiki Y, Ishida T, Suzuki K, Shimada K, Tomita A, Kato M, Ota Y, Izutsu K, Demachi-Okamura A, Akatsuka Y, Miyano S, Yoshino T, Gaulard P, Hermine O, Takeuchi K, Ohshima K, Ogawa S.

Leukemia. 2019 Jan 25. doi: 10.1038/s41375-019-0380-5. [Epub ahead of print]

PMID:
30683910
7.

Defective Epstein-Barr virus in chronic active infection and haematological malignancy.

Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H.

Nat Microbiol. 2019 Jan 21. doi: 10.1038/s41564-018-0334-0. [Epub ahead of print] Erratum in: Nat Microbiol. 2019 Jan 30;:.

PMID:
30664667
8.

Human leukocyte antigen class II expression is a good prognostic factor of adult T-cell leukemia/lymphoma.

Takeuchi M, Miyoshi H, Asano N, Yoshida N, Yamada K, Yanagida E, Moritsubo M, Nakata M, Umeno T, Suzuki T, Komaki S, Muta H, Furuta T, Seto M, Ohshima K.

Haematologica. 2019 Jan 10. pii: haematol.2018.205567. doi: 10.3324/haematol.2018.205567. [Epub ahead of print]

9.

Is clinicopathological distinction of mucosa-associated lymphoid tissue lymphoma from Waldenström macroglobulinemia essential in MYD88 L265P mutation-positive cases?

Kidoguchi K, Kojima K, Seki R, Nagafuji K, Ohshima K, Kimura S.

Int J Hematol. 2019 Jan 3. doi: 10.1007/s12185-018-02585-8. [Epub ahead of print] No abstract available.

PMID:
30604315
10.

Malignant progression of an extraventricular neurocytoma arising from the VIIIth cranial nerve: A case report and literature review.

Sugita Y, Furuta T, Komaki S, Ohshima K, Sakata K, Morioka M.

Neuropathology. 2018 Dec 26. doi: 10.1111/neup.12533. [Epub ahead of print]

PMID:
30588667
11.

Complete Genome Sequences of Seven Peanut Stunt Virus Strains from Japan.

Takahashi H, Ogawa A, Inoue S, Yasaka R, Ohshima K, Ugaki M, Suzuki M.

Microbiol Resour Announc. 2018 Sep 27;7(12). pii: e00952-18. doi: 10.1128/MRA.00952-18. eCollection 2018 Sep.

12.

An autopsy case of progressive multifocal leukoencephalopathy after rituximab therapy for malignant lymphoma.

Muto R, Sugita Y, Momosaki S, Ito Y, Wakugawa Y, Ohshima K.

Neuropathology. 2019 Feb;39(1):58-63. doi: 10.1111/neup.12526. Epub 2018 Dec 3.

PMID:
30511425
13.

Comparative proteomic analysis identifies exosomal Eps8 protein as a potential metastatic biomarker for pancreatic cancer.

Ohshima K, Hatakeyama K, Kanto K, Ide T, Watanabe Y, Moromizato S, Wakabayashi-Nakao K, Sakura N, Yamaguchi K, Mochizuki T.

Oncol Rep. 2019 Feb;41(2):1019-1034. doi: 10.3892/or.2018.6869. Epub 2018 Nov 15.

PMID:
30431134
14.

Locally distributed multicentric plasmacytomas in the ileum secondary to lymphoma chemoimmunotherapy.

Yokoo M, Kojima K, Sano H, Kai K, Arakawa F, Ohshima K, Matsunaga T, Kimura S.

Ann Hematol. 2018 Nov 8. doi: 10.1007/s00277-018-3543-y. [Epub ahead of print] No abstract available.

PMID:
30406822
15.

Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L-asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase negative.

Kawamoto K, Suzuki T, Kasami T, Kiryu M, Sone H, Miyoshi H, Ohshima K, Takizawa J.

Hematol Oncol. 2018 Nov 5. doi: 10.1002/hon.2565. [Epub ahead of print] No abstract available.

PMID:
30394560
16.

Classification of tumor microenvironment immune types based on immune response-associated gene expression.

Kondou R, Iizuka A, Nonomura C, Miyata H, Ashizawa T, Nagashima T, Ohshima K, Urakami K, Kusuhara M, Yamaguchi K, Akiyama Y.

Int J Oncol. 2019 Jan;54(1):219-228. doi: 10.3892/ijo.2018.4617. Epub 2018 Nov 2.

PMID:
30387832
17.

Multifunctional Actions of Ninjinyoeito, a Japanese Kampo Medicine: Accumulated Scientific Evidence Based on Experiments With Cells and Animal Models, and Clinical Studies.

Miyano K, Nonaka M, Uzu M, Ohshima K, Uezono Y.

Front Nutr. 2018 Oct 8;5:93. doi: 10.3389/fnut.2018.00093. eCollection 2018. Review.

18.

Modification of cellular and humoral immunity by somatically reverted T cells in X-linked lymphoproliferative syndrome type 1.

Hoshino A, Yang X, Tanita K, Yoshida K, Ono T, Nishida N, Okuno Y, Kanzaki T, Goi K, Fujino H, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Kojima S, Morio T, Kanegane H.

J Allergy Clin Immunol. 2019 Jan;143(1):421-424.e11. doi: 10.1016/j.jaci.2018.07.044. Epub 2018 Oct 17. No abstract available.

PMID:
30342818
19.

Epidemiology and secular trends of malignant lymphoma in Japan: Analysis of 9426 cases according to the World Health Organization classification.

Muto R, Miyoshi H, Sato K, Furuta T, Muta H, Kawamoto K, Yanagida E, Yamada K, Ohshima K.

Cancer Med. 2018 Nov;7(11):5843-5858. doi: 10.1002/cam4.1805. Epub 2018 Oct 11.

20.

Analysis of GNA13 Protein in Follicular Lymphoma and its Association With Poor Prognosis.

Shimono J, Miyoshi H, Yoshida N, Kato T, Sato K, Sugio T, Miyawaki K, Kurita D, Sasaki Y, Kawamoto K, Imaizumi Y, Kato K, Nagafuji K, Akashi K, Seto M, Teshima T, Ohshima K.

Am J Surg Pathol. 2018 Nov;42(11):1466-1471. doi: 10.1097/PAS.0000000000000969.

PMID:
30307409
21.

Successful treatment of an elderly Langerhans cell sarcoma patient by EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) chemotherapy.

Matsukawa T, Suto K, Miyoshi H, Oshimi K, Ohshima K, Miyagishima T.

J Clin Exp Hematop. 2018 Dec 13;58(4):184-187. doi: 10.3960/jslrt.18027. Epub 2018 Oct 10. No abstract available.

PMID:
30305476
Free Article
22.

Cladribine treatment for Erdheim-Chester disease involving the central nervous system and concomitant polycythemia vera: A case report.

Tamura S, Kawamoto K, Miyoshi H, Suzuki T, Katagiri T, Kasami T, Nemoto H, Miyakoshi S, Kobayashi H, Shibasaki Y, Masuko M, Takeuchi K, Ohshima K, Sone H, Takizawa J.

J Clin Exp Hematop. 2018 Dec 13;58(4):161-165. doi: 10.3960/jslrt.18015. Epub 2018 Oct 10.

23.

Genetic Diversity among Clouded Salamanders (Hynobius nebulosus) in Shiga Prefecture.

Mito N, Ohshima K, Saitoh O.

Zoolog Sci. 2018 Oct;35(5):427-435. doi: 10.2108/zs170095.

PMID:
30298788
24.

Oral ulceration: an unusual manifestation of lymphomatoid granulomatosis.

Kidoguchi K, Yoshimura M, Kojima K, Ureshino H, Egashira R, Yokoo M, Kai K, Egashira Y, Ohshima K, Ando T, Kimura S.

Ann Hematol. 2018 Oct 3. doi: 10.1007/s00277-018-3506-3. [Epub ahead of print] No abstract available.

PMID:
30284019
25.

Origin of cancer-associated fibroblasts and tumor-associated macrophages in humans after sex-mismatched bone marrow transplantation.

Kurashige M, Kohara M, Ohshima K, Tahara S, Hori Y, Nojima S, Wada N, Ikeda JI, Miyamura K, Ito M, Morii E.

Commun Biol. 2018 Sep 3;1:131. doi: 10.1038/s42003-018-0137-0. eCollection 2018.

26.

Synchronous case of follicular lymphoma and Langerhans cell sarcoma in the same lymph node.

Shimono J, Miyoshi H, Arakawa F, Abe H, Miyagishima T, Akiba J, Teshima T, Ohshima K.

Pathol Int. 2018 Nov;68(11):614-617. doi: 10.1111/pin.12722. Epub 2018 Sep 25.

PMID:
30255584
27.

Gemcitabine, Dexamethasone, and Cisplatin Regimen as an Effective Salvage Therapy for High-grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements.

Mitobe M, Kawamoto K, Suzuki T, Kiryu M, Tamura S, Nanba A, Suwabe T, Tanaka T, Fuse K, Shibasaki Y, Masuko M, Miyoshi H, Ohshima K, Sone H, Takizawa J.

Intern Med. 2019 Feb 15;58(4):575-580. doi: 10.2169/internalmedicine.1686-18. Epub 2018 Sep 12.

28.

Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS.

Sugio T, Miyawaki K, Kato K, Sasaki K, Yamada K, Iqbal J, Miyamoto T, Ohshima K, Maeda T, Miyoshi H, Akashi K.

Blood Adv. 2018 Sep 11;2(17):2242-2252. doi: 10.1182/bloodadvances.2018018754.

29.

Effect of glutamine on lymphoplasmacytic lymphoma, especially on the viewpoint of the differentiation into vulnerable subpopulation.

Wada N, Nojima S, Tahara SI, Ohshima K, Kurashige M, Kawasaki K, Tone M, Kusumoto S, Ikeda JI, Morii E.

Pathol Res Pract. 2018 Oct;214(10):1667-1674. doi: 10.1016/j.prp.2018.08.019. Epub 2018 Aug 27.

PMID:
30173943
30.

Successful treatment of monomorphic epitheliotropic intestinal T cell lymphoma with pralatrexate.

Tabata R, Tabata C, Okamura M, Takei Y, Ohshima K.

Ann Hematol. 2018 Sep 1. doi: 10.1007/s00277-018-3491-6. [Epub ahead of print] No abstract available.

PMID:
30173289
31.

Clinicopathological and immunohistochemical analysis of autoimmune regulator expression in patients with osteosarcoma.

Matsuda K, Miyoshi H, Moritsubo M, Hiraoka K, Hamada T, Shiba N, Ohshima K.

Clin Exp Metastasis. 2018 Oct;35(7):641-648. doi: 10.1007/s10585-018-9928-4. Epub 2018 Aug 18.

PMID:
30121939
32.

Transcriptional activation of a chimeric retrogene PIPSL in a hominoid ancestor.

Matsumura K, Imai H, Go Y, Kusuhara M, Yamaguchi K, Shirai T, Ohshima K.

Gene. 2018 Dec 15;678:318-323. doi: 10.1016/j.gene.2018.08.033. Epub 2018 Aug 8.

PMID:
30096459
33.

Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.

Matsuda K, Miyoshi H, Hiraoka K, Hamada T, Nakashima K, Shiba N, Ohshima K.

Clin Orthop Relat Res. 2018 Sep;476(9):1848-1855. doi: 10.1097/CORR.0000000000000379.

PMID:
30024460
34.

Effects of infection by Turnip mosaic virus on the population growth of generalist and specialist aphid vectors on turnip plants.

Adachi S, Honma T, Yasaka R, Ohshima K, Tokuda M.

PLoS One. 2018 Jul 17;13(7):e0200784. doi: 10.1371/journal.pone.0200784. eCollection 2018.

35.

Methotrexate-associated lymphoproliferative disorders with angioimmunoblastic T-cell lymphoma-like features accompanied by gamma-heavy chain disease in a patient with rheumatoid arthritis.

Kiyasu J, Arakawa F, Haji S, Tachikawa Y, Tsuda M, Tsukamoto Y, Ikeda M, Muta H, Matsushima T, Miyoshi H, Shiratsuchi M, Ogawa Y, Ohshima K, Yufu Y.

Pathol Int. 2018 Jul 10. doi: 10.1111/pin.12703. [Epub ahead of print]

PMID:
29987858
36.

Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis.

Matsuda K, Miyoshi H, Hiraoka K, Hamada T, Yoshida S, Ishibashi Y, Haraguchi T, Shiba N, Ohshima K.

Clin Exp Med. 2018 Nov;18(4):487-494. doi: 10.1007/s10238-018-0515-4. Epub 2018 Jun 30.

PMID:
29961175
37.

Tumor mutational burden analysis of 2,000 Japanese cancer genomes using whole exome and targeted gene panel sequencing.

Hatakeyama K, Nagashima T, Urakami K, Ohshima K, Serizawa M, Ohnami S, Shimoda Y, Ohnami S, Maruyama K, Naruoka A, Akiyama Y, Kusuhara M, Mochizuki T, Yamaguchi K.

Biomed Res. 2018;39(3):159-167. doi: 10.2220/biomedres.39.159.

38.

Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations.

Hatakeyama K, Ohshima K, Nagashima T, Ohnami S, Ohnami S, Serizawa M, Shimoda Y, Maruyama K, Akiyama Y, Urakami K, Kusuhara M, Mochizuki T, Yamaguchi K.

Sci Rep. 2018 Jun 7;8(1):8700. doi: 10.1038/s41598-018-26967-4.

39.

[The microenvironment and immune status of peripheral T-cell lymphoma: focusing on AITL and ATLL].

Ohshima K, Miyoshi H, Yamada K.

Rinsho Ketsueki. 2018;59(5):574-587. doi: 10.11406/rinketsu.59.574. Japanese.

PMID:
29877249
40.

Cross-Kingdom Commonality of a Novel Insertion Signature of RTE-Related Short Retroposons.

Nishiyama E, Ohshima K.

Genome Biol Evol. 2018 Jun 1;10(6):1471-1483. doi: 10.1093/gbe/evy098.

41.

Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.

Sakamoto K, Katayama R, Asaka R, Sakata S, Baba S, Nakasone H, Koike S, Tsuyama N, Dobashi A, Sasaki M, Ichinohasama R, Takakuwa E, Yamazaki R, Takizawa J, Maeda T, Narita M, Izutsu K, Kanda Y, Ohshima K, Takeuchi K.

Leukemia. 2018 Dec;32(12):2590-2603. doi: 10.1038/s41375-018-0154-5. Epub 2018 May 23.

PMID:
29795241
42.

Clinicopathological analysis of immunohistochemical expression of retinoic acid-related orphan receptor-γt in peripheral T-cell lymphoma, not otherwise specified.

Yanagida E, Miyoshi H, Kawamoto K, Nakashima K, Matsuda K, Yamada K, Muto R, Nagafuji K, Seto M, Ohshima K.

Hum Pathol. 2018 Sep;79:86-92. doi: 10.1016/j.humpath.2018.05.002. Epub 2018 Jun 22.

PMID:
29775622
43.

The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma.

Ashida R, Okamura Y, Ohshima K, Kakuda Y, Uesaka K, Sugiura T, Ito T, Yamamoto Y, Sugino T, Urakami K, Kusuhara M, Yamaguchi K.

Oncotarget. 2018 Apr 24;9(31):22058-22068. doi: 10.18632/oncotarget.25178. eCollection 2018 Apr 24.

44.

Two cases of acute pneumococcal purulent arthritis.

Seki M, Chang B, Ohshima K, Watanabe Y.

IDCases. 2018 Mar 6;12:13-15. doi: 10.1016/j.idcr.2018.02.010. eCollection 2018.

45.

Coronary artery-left ventricular shunt: an important cause of chest pain in patients with hypertrophic cardiomyopathy.

Hamada M, Ogimoto A, Ohshima K, Miyazaki S, Kubota N, Ikeda S, Shigematsu Y.

Heart Vessels. 2018 Nov;33(11):1267-1274. doi: 10.1007/s00380-018-1178-5. Epub 2018 May 2.

PMID:
29721675
46.

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.

Dufva O, Kankainen M, Kelkka T, Sekiguchi N, Awad SA, Eldfors S, Yadav B, Kuusanmäki H, Malani D, Andersson EI, Pietarinen P, Saikko L, Kovanen PE, Ojala T, Lee DA, Loughran TP Jr, Nakazawa H, Suzumiya J, Suzuki R, Ko YH, Kim WS, Chuang SS, Aittokallio T, Chan WC, Ohshima K, Ishida F, Mustjoki S.

Nat Commun. 2018 Apr 19;9(1):1567. doi: 10.1038/s41467-018-03987-2.

47.

Clinicopathological analysis of polyploid diffuse large B-cell lymphoma.

Shimono J, Miyoshi H, Kiyasu J, Kamimura T, Eto T, Miyagishima T, Nagafuji K, Seto M, Teshima T, Ohshima K.

PLoS One. 2018 Apr 11;13(4):e0194525. doi: 10.1371/journal.pone.0194525. eCollection 2018.

48.

[Splenic diffuse red pulp small B-cell lymphoma diagnosed by splenectomy initially mimicking hairy cell leukemia-Japanese variant].

Yamada Y, Miura M, Tagari M, Oshimi K, Shiragata T, Suga W, Takahashi T, Shimizu K, Ohshima K, Kajiwara K.

Rinsho Ketsueki. 2018;59(3):281-286. doi: 10.11406/rinketsu.59.281. Japanese.

PMID:
29618685
49.

An autopsy case report: Differences in radiological images correlate with histology in Erdheim-Chester disease.

Ohara Y, Kato S, Yamashita D, Satou A, Shimoyama Y, Hamaie C, Sato M, Ban N, Yamamoto K, Yamada T, Kawai H, Ohshima K, Nakamura S, Toyokuni S.

Pathol Int. 2018 Jun;68(6):374-381. doi: 10.1111/pin.12663. Epub 2018 Mar 30.

PMID:
29603831
50.

Expression of programmed death ligand 1 is associated with poor prognosis in myeloid sarcoma patients.

Kawamoto K, Miyoshi H, Suzuki T, Kiyasu J, Yokoyama S, Sasaki Y, Sone H, Seto M, Takizawa J, Ohshima K.

Hematol Oncol. 2018 Mar 30. doi: 10.1002/hon.2506. [Epub ahead of print]

PMID:
29602174

Supplemental Content

Loading ...
Support Center